[
  {
    "ts": null,
    "headline": "UnitedHealth Vs. Centene: Next Week's Q3 Earnings Should Trigger Gains For Both",
    "summary": "UnitedHealth Group Incorporated and Centene Corporation remain heavily discounted after recent selloffs. Learn more about UNH and CNC stocks here.",
    "url": "https://finnhub.io/api/news?id=37ff175dfd8a00cbe0c9f322ceae7e23d1869d64593c6dc8276c2128e71588ac",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761306593,
      "headline": "UnitedHealth Vs. Centene: Next Week's Q3 Earnings Should Trigger Gains For Both",
      "id": 137202626,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1371723531/image_1371723531.jpg?io=getty-c-w1536",
      "related": "CNC",
      "source": "SeekingAlpha",
      "summary": "UnitedHealth Group Incorporated and Centene Corporation remain heavily discounted after recent selloffs. Learn more about UNH and CNC stocks here.",
      "url": "https://finnhub.io/api/news?id=37ff175dfd8a00cbe0c9f322ceae7e23d1869d64593c6dc8276c2128e71588ac"
    }
  },
  {
    "ts": null,
    "headline": "Molina Healthcare: Looks Like A Sick Puppy",
    "summary": "Molina Healthcare (MOH) reported weak Q3 results, slashing EPS guidance due to rising medical costs and broad margin deterioration.",
    "url": "https://finnhub.io/api/news?id=1b8920843b91cf3795bb694b5623d5869a23134db84189d1f94ca571841c1c99",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761293153,
      "headline": "Molina Healthcare: Looks Like A Sick Puppy",
      "id": 137201873,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303505166/image_1303505166.jpg?io=getty-c-w1536",
      "related": "CNC",
      "source": "SeekingAlpha",
      "summary": "Molina Healthcare (MOH) reported weak Q3 results, slashing EPS guidance due to rising medical costs and broad margin deterioration.",
      "url": "https://finnhub.io/api/news?id=1b8920843b91cf3795bb694b5623d5869a23134db84189d1f94ca571841c1c99"
    }
  },
  {
    "ts": null,
    "headline": "Why The Narrative Around Centene Is Shifting After Analyst Upgrades and New Sector Risks",
    "summary": "Centene stock has attracted renewed interest from analysts after its consensus price target increased from $34.63 to $36.00. This marks a modest but notable upward adjustment in fair value expectations. This change comes as investor sentiment balances optimism around earnings visibility and margin recovery with ongoing sector challenges. Stay tuned to learn how you can keep on top of the shifting narrative and key drivers shaping Centene’s outlook in the coming months. What Wall Street Has...",
    "url": "https://finnhub.io/api/news?id=fba1ce7f4255d6bc5edb498542f48745a70a21aaeceb7d4e09d41221baca13f6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761285985,
      "headline": "Why The Narrative Around Centene Is Shifting After Analyst Upgrades and New Sector Risks",
      "id": 137217235,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CNC",
      "source": "Yahoo",
      "summary": "Centene stock has attracted renewed interest from analysts after its consensus price target increased from $34.63 to $36.00. This marks a modest but notable upward adjustment in fair value expectations. This change comes as investor sentiment balances optimism around earnings visibility and margin recovery with ongoing sector challenges. Stay tuned to learn how you can keep on top of the shifting narrative and key drivers shaping Centene’s outlook in the coming months. What Wall Street Has...",
      "url": "https://finnhub.io/api/news?id=fba1ce7f4255d6bc5edb498542f48745a70a21aaeceb7d4e09d41221baca13f6"
    }
  },
  {
    "ts": null,
    "headline": "Smart Acquisitions And Profit Margin Growth Amid Strategic Repositioning",
    "summary": "Invesco highlights strategic fund shifts and key contributors driving Q3 growth. Explore how smart repositioning supports long-term potentialâread the full update.",
    "url": "https://finnhub.io/api/news?id=1ce4d328f1a2874bd45e9b25f925cf2c759f7c0ee73e7aa7f6f6038fe80df53a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761280200,
      "headline": "Smart Acquisitions And Profit Margin Growth Amid Strategic Repositioning",
      "id": 137201175,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2192908520/image_2192908520.jpg?io=getty-c-w1536",
      "related": "CNC",
      "source": "SeekingAlpha",
      "summary": "Invesco highlights strategic fund shifts and key contributors driving Q3 growth. Explore how smart repositioning supports long-term potentialâread the full update.",
      "url": "https://finnhub.io/api/news?id=1ce4d328f1a2874bd45e9b25f925cf2c759f7c0ee73e7aa7f6f6038fe80df53a"
    }
  },
  {
    "ts": null,
    "headline": "Elevance Health: Q3 Figures Underscore Slow But Steady Recovery",
    "summary": "Elevance Health targets 12% EPS growth with a forward P/E of 11.5 and steady results supporting guidance. See why ELV stock is a buy.",
    "url": "https://finnhub.io/api/news?id=d0825654b6fcc6fea791c355c5114213407ebb0cb41ee5b25cb48c2351c2ab16",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761276550,
      "headline": "Elevance Health: Q3 Figures Underscore Slow But Steady Recovery",
      "id": 137200996,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2164256928/image_2164256928.jpg?io=getty-c-w1536",
      "related": "CNC",
      "source": "SeekingAlpha",
      "summary": "Elevance Health targets 12% EPS growth with a forward P/E of 11.5 and steady results supporting guidance. See why ELV stock is a buy.",
      "url": "https://finnhub.io/api/news?id=d0825654b6fcc6fea791c355c5114213407ebb0cb41ee5b25cb48c2351c2ab16"
    }
  }
]